Alexander B Olawaiye, MD
4 clinical trials · Sponsor
◉ Watch Alexander B Olawaiye, MD
| Record | Firm | Date |
|---|---|---|
| Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency (NCT06120972) | Alexander B Olawaiye, MD | 2024-01-17 |
| ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer (NCT05071937) | Alexander B Olawaiye, MD | 2023-04-21 |
| Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer (NCT05467670) | Alexander B Olawaiye, MD | 2023-03-30 |
| T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors (NCT05200559) | Alexander B Olawaiye, MD | 2022-09-30 |
Track Alexander B Olawaiye, MD automatically
Every clearance here is in the API, with alerts when new ones post.